Back to top
more

Corgi MU 2x Daily ETF: (MIC)

(Delayed Data from NYSE MKT (ex. AMEX)) As of Aug 20, 2026 04:00 PM ET

$13.56 USD

13.56
46,051

+0.76 (5.91%)

Volume: 46,051

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

NA

After-Market: $13.90 +0.34 (2.51 %) 7:58 PM ET

Zacks News

Zacks Equity Research

MRC Global (MRC) Q2 Earnings Surpass Estimates, Fall Y/Y

MRC Global's (MRC) second-quarter 2020 earnings and revenues suffer from persistent lower demand on account of restricted customer spending.

Zacks Equity Research

Barnes (B) Q2 Earnings Surpass Estimates, Revenues Miss

Barnes (B) second-quarter 2020 revenues decline 37% year over year on lackluster performance across its segments.

Zacks Equity Research

3M (MMM) Q2 Earnings Surpass Earnings, Fall Y/Y on Weak Sales

3M's (MMM) second-quarter 2020 results reflect the adverse impacts of the coronavirus outbreak, forex woes and inorganic actions, offset by lower taxes, a fall in share count and cost reduction.

Zacks Equity Research

Crane (CR) Q2 Earnings and Revenues Beat Estimates, Down Y/Y

Crane's (CR) second-quarter 2020 revenues decline 19.5% year over year on lackluster performance across its segments.

Zacks Equity Research

Roper (ROP) Q2 Earnings & Revenues Top Estimates, Decline Y/Y

Roper's (ROP) second-quarter 2020 revenues decline 2% year over year on weak performance across its Measurement & Analytical Solutions, and Process Technologies segments.

Zacks Equity Research

Analysts Estimate Macquarie (MIC) to Report a Decline in Earnings: What to Look Out for

Macquarie (MIC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Danaher (DHR) Beats on Q2 Earnings, Gives Impressive View

Danaher's (DHR) Q2 results gain from contribution from Cytiva and suffer from forex woes. Core sales in Q3 are expected to grow primarily on gains from Cytiva.

Zacks Equity Research

Top Ranked Income Stocks to Buy for July 23rd

Here are four stocks with buy rank and strong income characteristics for investors to consider today, July 23rd

Zacks Equity Research

Carlisle (CSL) Q2 Earnings & Revenues Surpass Estimates

Carlisle's (CSL) Q2 revenues decline 22.1% year over year, owing to lackluster performance across all of its segments on a decline in sales volume due to the coronavirus outbreak-led issues.

Zacks Equity Research

Top Ranked Income Stocks to Buy for July 21st

Here are three stocks with buy rank and strong income characteristics for investors to consider today, July 21st